ISB News

ISB Gets $2.3 million NIH Grant to Use Single-Cell Technology to Fight Cancer

Pictured above: Dr. Qiang Tian, left, and Dr. Edward Lin, right, discuss single-cell analysis technologies developed at Institute for Systems Biology in Seattle.

September 22, 2014 – ISB has received a $2.3 million NIH grant over four years in response to NCI’s “Provocative Questions” Initiative. The project will apply ISB’s most advanced single-cell omics technologies to an innovative clinical trial for colorectal cancer (ADAPT). Principal investigator Qiang Tian, MD, PhD, head of the Cancer & Stem Cell Group, explained that the goal is to identify single cell signatures that can be used to stratify those patients who respond well to the treatment from those who are resistant to the treatment. For the patients who do not respond, the hope is to figure out a better treatment scheme from the study.

A comment from one of the proposal reviewers stated: “Using clinical trial-treated tumors to characterize the sub-grouping could lead to changes in future regimens and will provide a wealth of translational knowledge. (This) will answer questions about cellular resistance which has many implications on treatment regimens. This potentially can have broad ranging implications in understanding tumor resistance, how treatment fails and future chemotherapy regimens, all of which would be highly significant.”

ISB is collaborating on this research with Dr. Edward Lin, a medical oncologist at Seattle Cancer Care Alliance, associate member of Fred Hutchinson Cancer Research Center, and associate professor at the University of Washington. Dr. Lin was named 2014 Cancer Researcher of the Year by The Gateway For Cancer Research organization.

Acknowledgment: This research is supported by the National Cancer Institute of the National Institutes of Health under Award Number R01CA190122. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The ADAPT trial is funded by The Gateway for Cancer Research.

 

Recent Articles

  • Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

    ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs: How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”

  • Drs. Serdar Turkarslan and Christian Diener

    ISB Honors Researchers Who Give Back to STEM Education

    This year, two deserving scientists were bestowed recognition for giving back to STEM education. Dr. Serdar Turkarslan is the recipient of the JoAnn Chrisman Award for Distinguished Service to STEM Education, and Dr. Christian Diener was awarded the Dr. Christine Schaeffer Award for Exemplary Service to STEM Education. 

  • Spotlight on ISB Education graphic

    2021-22 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.